Skip to content
CMCMCM611611611

Drawing based on the label description. No photo yet.

CM 611 pill

Pill with imprint CM 611 is purple, oval, 22 mm and has been identified as Canagliflozin and Metformin Hydrochloride 150 mg / 1000 mg. It is used for type 2 diabetes. It is supplied by Janssen Pharmaceuticals, Inc.

Canagliflozin and Metformin Hydrochloride 150 mg / 1000 mg

Imprint
CM 611
Strength
Canagliflozin Anhydrous 150 mg / Metformin Hydrochloride 1000 mg
Used for
Type 2 diabetes
Color
Purple
Shape
Oval
Size
22 mm
Score
No score line
Form
Tablet, film coated
Manufacturer
Janssen Pharmaceuticals, Inc
Drug class
Diabetes medicine (SGLT2 inhibitor)
NDC
50458-543, 50458-543-60, 50458-543-91

Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Canagliflozin and Metformin pills and guides

What is Canagliflozin and Metformin used for?

Canagliflozin and Metformin is used for type 2 diabetes.

Medicine type
Diabetes medicine (SGLT2 inhibitor); diabetes medicine (biguanide)
Official uses from the US prescribing label

INVOKAMET

INVOKAMET is a combination of canagliflozin and metformin HCl immediate-release indicated as an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients aged 10 years and older with type 2 diabetes mellitus.

INVOKAMET XR

INVOKAMET XR is a combination of canagliflozin and metformin HCl extended-release indicated as an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients aged 10 years and older with type 2 diabetes mellitus.

Canagliflozin

Canagliflozin, when used as a component of INVOKAMET or INVOKAMET XR, is indicated in adults with type 2 diabetes mellitus to reduce the risk of:

  • Major adverse cardiovascular events (cardiovascular death, nonfatal myocardial infarction and nonfatal stroke) in adults with type 2 diabetes mellitus and established cardiovascular disease (CVD).
  • End-stage kidney disease (ESKD), doubling of serum creatinine, cardiovascular (CV) death, and hospitalization for heart failure in adults with type 2 diabetes mellitus and diabetic nephropathy with albuminuria greater than 300 mg/day.

Limitations of Use

INVOKAMET or INVOKAMET XR are not recommended for use to improve glycemic control in patients with type 1 diabetes mellitus.

From the FDA-approved label on DailyMed (published Aug 25, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your pill? Check every detail

  • Your pill shows CM 611. The parts can be split between the two sides, so turn the pill over and check both.
  • It is purple, oval, 22 mm.
  • Its score line and coating match the details on this page.
  • It came from a pharmacy package that names the same drug.

Sold under the brand name Invokamet.

Ingredients

Active: Canagliflozin, Metformin Hydrochloride

Inactive: Croscarmellose Sodium, Hypromellose, Unspecified, Magnesium Stearate, Microcrystalline Cellulose, Water, Polyethylene Glycol 3350, Polyvinyl Alcohol, Unspecified, Talc, Titanium Dioxide, Ferric Oxide Red, Ferrosoferric Oxide

Pills that look similar but are different drugs

Same color and shape, different medicine. This is why the imprint matters.

Other Canagliflozin and Metformin pills